News
Evercore has agreed to buy elite UK advisory firm Robey Warshaw for $196mn, as the US investment bank steps up its challenge ...
9d
GlobalData on MSNARCHIMED to acquire life sciences company ZimVie for $730mZimVie’s board of directors granted unanimous approval for the transaction, anticipated to be finalised by the end of this ...
(Reuters) -Oilfield services firm Baker Hughes said on Tuesday it would buy Chart Industries in a $13.6 billion all-cash deal ...
9d
GlobalData on MSNJ.P. Morgan, Houlihan Lokey lead consumer sector financial adviser M&A rankings in H1In the value-based rankings, Citi secured second place with $4.5bn in advised deals, followed by Centerview Partners at ...
Bausch Health to acquire DURECT Corporation, strengthening commitment to developing innovative solutions for patients with liver disease: Laval, Quebec Wednesday, July 30, 2025, 1 ...
Pinnacle Financial Partners (Nasdaq/NGS: PNFP) and Synovus Financial Corp. (NYSE: SNV) today announced that they have entered into a definitive agreement to combine in an all-stock transaction valued ...
Monday announced their entry into a definitive agreement according to which ZimVie will be acquired by an affiliate of Archimed, an investment firm focused exclusively on healthcare industries.
Eli Lilly and Company (NYSE: LLY) and Verve Therapeutics, Inc. (NASDAQ: VERV) today announced that the tender offer to ...
DURECT's lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy DesignationPotential to be the first FDA-approved therapeutic option for the treatment of patients with alc ...
Kenvue appoints Kirk Perry as interim CEO after Thibaut Mongon's exit and launches strategic review to simplify operations.
Merck has entered a definitive agreement to acquire biopharmaceutical company Verona Pharma in a deal valued at $10bn.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results